TALEN

TALEN3-cyp19a1a

ID
ZDB-TALEN-171120-4
Name
TALEN3-cyp19a1a
Previous Names
None
Target
Target Sequence 1
5' - AAGGAAGTCTTTGTAC - 3'
ZFIN BLAST NCBI BLAST Ensembl
Target Sequence 2
5' - GCAGACCCAGTTTACT - 3'
ZFIN BLAST NCBI BLAST Ensembl
Disclaimer
Although ZFIN verifies reagent sequence data, we recommend that you conduct independent sequence analysis before ordering any reagent.
Note
None
Genome Resources
None
Target Location
Constructs
No data available
Genomic Features
Genomic Feature Affected Genomic Regions
zf1031 cyp19a1a
Expression
Gene expression in Wild Types + TALEN3-cyp19a1a
No data available
Phenotype
Phenotype resulting from TALEN3-cyp19a1a
No data available
Phenotype of all Fish created by or utilizing TALEN3-cyp19a1a
Phenotype Fish Conditions Figures
whole organism sox9a expression amount, ameliorated cyp19a1azf1031/zf1031 (AB) chemical treatment by environment: 17beta-estradiol Fig. 7 from Yin et al., 2017
whole organism ar expression decreased amount, abnormal cyp19a1azf1031/zf1031 (AB) standard conditions Fig. 7 from Yin et al., 2017
male gonad development delayed, ameliorated cyp19a1azf1031/zf1031 (AB) chemical treatment by environment: 17beta-estradiol Fig. 6 from Yin et al., 2017
female organism estradiol decreased amount, abnormal cyp19a1azf1031/zf1031 (AB) chemical treatment by environment: 17beta-estradiol Fig. 4 from Yin et al., 2017
whole organism dmrt1 expression amount, ameliorated cyp19a1azf1031/zf1031 (AB) chemical treatment by environment: 17beta-estradiol Fig. 7 from Yin et al., 2017
whole organism foxl2a expression decreased amount, abnormal cyp19a1azf1031/zf1031 (AB) standard conditions Fig. 7 from Yin et al., 2017
blood estradiol absent, abnormal cyp19a1azf1031/zf1031 (AB) standard conditions Fig. 2 from Yin et al., 2017
whole organism amh expression decreased amount, abnormal cyp19a1azf1031/zf1031 (AB) standard conditions Fig. 7 from Yin et al., 2017
whole organism sox9a expression decreased amount, abnormal cyp19a1azf1031/zf1031 (AB) standard conditions Fig. 7 from Yin et al., 2017
immature gonad absent, abnormal cyp19a1azf1031/zf1031 (AB) standard conditions Fig. 6 from Yin et al., 2017
male organism 11-oxotestosterone increased amount, abnormal cyp19a1azf1031/zf1031 (AB) standard conditions Fig. 3 from Yin et al., 2017
female sex determination disrupted, abnormal cyp19a1azf1031/zf1031 (AB) standard conditions Fig. 2 from Yin et al., 2017
male organism ratio female organism, abnormal cyp19a1azf1031/zf1031 (AB) standard conditions Fig. 2 from Yin et al., 2017
whole organism dmrt1 expression decreased amount, abnormal cyp19a1azf1031/zf1031 (AB) standard conditions Fig. 7 from Yin et al., 2017
female organism present, ameliorated cyp19a1azf1031/zf1031 (AB) chemical treatment by environment: 17beta-estradiol Fig. 4 from Yin et al., 2017
male organism present, ameliorated cyp19a1azf1031/zf1031 (AB) chemical treatment by environment: 17beta-estradiol Fig. 4 from Yin et al., 2017
whole organism sf1 expression decreased amount, abnormal cyp19a1azf1031/zf1031 (AB) standard conditions Fig. 7 from Yin et al., 2017
whole organism amh expression amount, ameliorated cyp19a1azf1031/zf1031 (AB) chemical treatment by environment: 17beta-estradiol Fig. 7 from Yin et al., 2017
whole organism ar expression decreased amount, abnormal cyp19a1azf1031/zf1031 (AB) chemical treatment by environment: 17beta-estradiol Fig. 7 from Yin et al., 2017
whole organism amh expression decreased amount, abnormal cyp19a1azf1031/zf1031 (AB) chemical treatment by environment: 17beta-estradiol Fig. 7 from Yin et al., 2017
immature gonad present, ameliorated cyp19a1azf1031/zf1031 (AB) chemical treatment by environment: 17beta-estradiol Fig. 6 from Yin et al., 2017
female organism absent, abnormal cyp19a1azf1031/zf1031 (AB) standard conditions Fig. 2 from Yin et al., 2017
whole organism foxl2a expression amount, ameliorated cyp19a1azf1031/zf1031 (AB) chemical treatment by environment: 17beta-estradiol Fig. 7 from Yin et al., 2017
male gonad development delayed, abnormal cyp19a1azf1031/zf1031 (AB) standard conditions Fig. 6 from Yin et al., 2017
whole organism sf1 expression decreased amount, abnormal cyp19a1azf1031/zf1031 (AB) chemical treatment by environment: 17beta-estradiol Fig. 7 from Yin et al., 2017
female sex determination occurrence, ameliorated cyp19a1azf1031/zf1031 (AB) chemical treatment by environment: 17beta-estradiol Fig. 4 from Yin et al., 2017
whole organism sf1 expression amount, ameliorated cyp19a1azf1031/zf1031 (AB) chemical treatment by environment: 17beta-estradiol Fig. 7 from Yin et al., 2017
male organism testosterone increased amount, abnormal cyp19a1azf1031/zf1031 (AB) standard conditions Fig. 3 from Yin et al., 2017
male organism ratio female organism, abnormal cyp19a1azf1031/zf1031; cyp19a1bzf1032/zf1032 (AB) standard conditions Fig. 2 from Yin et al., 2017
female organism absent, abnormal cyp19a1azf1031/zf1031; cyp19a1bzf1032/zf1032 (AB) standard conditions Fig. 2 from Yin et al., 2017
blood estradiol absent, abnormal cyp19a1azf1031/zf1031; cyp19a1bzf1032/zf1032 (AB) standard conditions Fig. 2 from Yin et al., 2017
female sex determination disrupted, abnormal cyp19a1azf1031/zf1031; cyp19a1bzf1032/zf1032 (AB) standard conditions Fig. 2 from Yin et al., 2017
male gonad development delayed, abnormal cyp19a1azf1031/zf1031; cyp19a1bzf1032/zf1032 (AB) chemical treatment by environment: 17beta-estradiol Fig. 6 from Yin et al., 2017
immature gonad absent, abnormal cyp19a1azf1031/zf1031; cyp19a1bzf1032/zf1032 (AB) chemical treatment by environment: 17beta-estradiol Fig. 6 from Yin et al., 2017
Citations
Your Input Welcome
We welcome your input and comments. Please use this form to recommend updates to the information in ZFIN. We appreciate as much detail as possible and references as appropriate. We will review your comments promptly.
Please check the highlighted fields and try again.
Thank you for submitting comments. Your input has been emailed to ZFIN curators who may contact you if additional information is required.
Oops. Something went wrong. Please try again later.